LifeMD, Inc. — Director's Dealing 2022

Dec 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-12-15

Reporting Person: Walsh Kathleen E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-15	Common Stock	A	75000	—	Acquired	75000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-15	Stock Option (Right to Buy)	$2.3	A	37500	Acquired	2027-12-15	Common Stock (37500)	Direct

Footnotes

F1: Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the Director received a one-time grant of 75,000 restricted shares, with 37,500 shares vesting immediately and the remaining 37,500 shares vesting on December 15, 2024.

F2: The option vests on December 15, 2024.